Company Filing History:
1 out of 1 
1 out of 1 
1 out of 2 Years Active: 2022
Title: Deliang Niu: Innovator in Pharmaceutical Chemistry
Introduction
Deliang Niu is a notable inventor based in Shanghai, China, recognized for his contributions to the field of pharmaceutical chemistry. With a focus on developing stable and pure compounds, he holds a patent that has significant implications for medicinal chemistry, specifically in the synthesis of important pharmaceutical agents.
Latest Patents
Deliang Niu's patent, titled "Crystal form of 3-(4-methyl-1H-imidazol-1-yl)-5-trifluoromethylaniline monohydrochloride and use thereof," describes a novel crystal form of a monohydrochloride anhydrous substance. The invention specifically details a method for preparing crystal form A of 3-(4-methyl-1H-imidazol-1-yl)-5-trifluoromethylaniline monohydrochloride and its application in the synthesis of nilotinib. The developed crystal form is noted for its good stability and purity, allowing for direct use in nilotinib preparation, highlighting its industrial application value.
Career Highlights
Throughout his career, Deliang Niu has worked with various prestigious companies, including Arizest Pharmatech Co., Ltd. and Jiangsu Xidi Pharmaceuticals Co., Ltd. His involvement in these organizations reflects his integral role in advancing pharmaceutical technologies and contributing to innovative research in drug development.
Collaborations
Deliang Niu has collaborated with several accomplished professionals in the pharmaceutical field, including Bojun Ma and Zhanqun Zhu. These partnerships have enabled him to enhance his research capabilities and foster a collaborative environment for innovation.
Conclusion
Deliang Niu's contributions to the field of pharmaceutical chemistry through his patented inventions demonstrate his commitment to advancing healthcare solutions. His innovative approaches not only pave the way for the efficient synthesis of important drugs like nilotinib but also emphasize the significance of stability and purity in pharmaceutical formulations. As he continues to collaborate with experts in the field, Deliang Niu remains a key figure in the ongoing pursuit of medical breakthroughs.